Biotechnology Assets, S.A. (BME:BST)
Spain · Delayed Price · Currency is EUR 0.2260
-0.0100 (-4.24%)
Jun 26, 2026, 5:35 PM CET
Biotechnology Assets Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3.43 | 2.97 | 3.91 | 2.96 | 3.28 | |
Revenue Growth (YoY) | 15.73% | -24.14% | 32.14% | -9.87% | 13.50% |
Cost of Revenue | 0.26 | 0.35 | 0.45 | 0.36 | 0.25 |
Gross Profit | 3.17 | 2.62 | 3.46 | 2.59 | 3.04 |
Selling, General & Admin | 2.44 | 2.95 | 2.96 | 2.56 | 3.33 |
Other Operating Expenses | -0.51 | -0.25 | -4.68 | -0.38 | -0.3 |
Operating Expenses | 3.94 | 4.9 | 0.75 | 4.33 | 5.11 |
Operating Income | -0.77 | -2.29 | 2.71 | -1.74 | -2.07 |
Interest Expense | -0.13 | -0.18 | -0.31 | -0.35 | -0.85 |
Interest & Investment Income | 0 | 0 | 0 | 0 | 0 |
Currency Exchange Gain (Loss) | -0.06 | -0.05 | -0.02 | 0.03 | 0.01 |
EBT Excluding Unusual Items | -0.96 | -2.52 | 2.38 | -2.05 | -2.91 |
Asset Writedown | -0.66 | -0.56 | -0.05 | - | - |
Other Unusual Items | 0.03 | 0.02 | 0 | 0.01 | 0 |
Pretax Income | -1.6 | -3.06 | 2.32 | -2.04 | -2.91 |
Income Tax Expense | 0.32 | -0.14 | 0.75 | -0.1 | 0.1 |
Earnings From Continuing Operations | -1.92 | -2.92 | 1.57 | -1.94 | -3.01 |
Net Income to Company | -1.92 | -2.92 | 1.57 | -1.94 | -3.01 |
Minority Interest in Earnings | 0 | - | -0 | 0 | 0 |
Net Income | -1.92 | -2.92 | 1.57 | -1.94 | -3.01 |
Net Income to Common | -1.92 | -2.92 | 1.57 | -1.94 | -3.01 |
Shares Outstanding (Basic) | 73 | 66 | 58 | 54 | 46 |
Shares Outstanding (Diluted) | 73 | 66 | 58 | 54 | 46 |
Shares Change (YoY) | 10.20% | 14.28% | 6.50% | 18.82% | 16.39% |
EPS (Basic) | -0.03 | -0.04 | 0.03 | -0.04 | -0.07 |
EPS (Diluted) | -0.03 | -0.04 | 0.03 | -0.04 | -0.07 |
Free Cash Flow | -0.02 | -0.09 | -0.02 | -0.14 | -1.52 |
Free Cash Flow Per Share | - | -0.00 | - | -0.00 | -0.03 |
Gross Margin | 92.52% | 88.19% | 88.47% | 87.67% | 92.49% |
Operating Margin | -22.35% | -77.17% | 69.28% | -58.71% | -63.22% |
Profit Margin | -55.84% | -98.39% | 40.27% | -65.70% | -91.80% |
Free Cash Flow Margin | -0.44% | -2.96% | -0.56% | -4.90% | -46.29% |
EBITDA | 0.16 | -1.29 | 3.72 | -0.71 | -1.04 |
EBITDA Margin | 4.65% | -43.60% | 95.23% | -24.04% | -31.79% |
D&A For EBITDA | 0.93 | 1 | 1.01 | 1.03 | 1.03 |
EBIT | -0.77 | -2.29 | 2.71 | -1.74 | -2.07 |
EBIT Margin | -22.35% | -77.17% | 69.28% | -58.71% | -63.22% |
Effective Tax Rate | - | - | 32.23% | - | - |
Advertising Expenses | 0.02 | 0.05 | 0.04 | 0.01 | 0.05 |